Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0030684 | preribosome | 3 | 1 |
GO:0030686 | 90S preribosome | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
GO:0005840 | ribosome | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043228 | non-membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HQL3
Term | Name | Level | Count |
---|---|---|---|
GO:0000470 | maturation of LSU-rRNA | 9 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 96 | 100 | PF00656 | 0.387 |
CLV_MEL_PAP_1 | 187 | 193 | PF00089 | 0.422 |
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.383 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.293 |
CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.352 |
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.267 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 84 | 86 | PF00675 | 0.310 |
CLV_PCSK_FUR_1 | 104 | 108 | PF00082 | 0.387 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.357 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.336 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.568 |
CLV_PCSK_PC1ET2_1 | 103 | 105 | PF00082 | 0.398 |
CLV_PCSK_PC1ET2_1 | 237 | 239 | PF00082 | 0.536 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.388 |
DEG_APCC_DBOX_1 | 59 | 67 | PF00400 | 0.422 |
DEG_SPOP_SBC_1 | 230 | 234 | PF00917 | 0.410 |
DEG_SPOP_SBC_1 | 24 | 28 | PF00917 | 0.355 |
DOC_CKS1_1 | 78 | 83 | PF01111 | 0.317 |
DOC_MAPK_gen_1 | 169 | 179 | PF00069 | 0.445 |
DOC_MAPK_gen_1 | 237 | 243 | PF00069 | 0.456 |
DOC_MAPK_MEF2A_6 | 222 | 229 | PF00069 | 0.422 |
DOC_MAPK_MEF2A_6 | 39 | 48 | PF00069 | 0.321 |
DOC_PP2B_LxvP_1 | 34 | 37 | PF13499 | 0.607 |
DOC_PP2B_LxvP_1 | 53 | 56 | PF13499 | 0.118 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.336 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.459 |
DOC_USP7_MATH_1 | 230 | 234 | PF00917 | 0.443 |
DOC_USP7_MATH_2 | 68 | 74 | PF00917 | 0.387 |
DOC_USP7_UBL2_3 | 113 | 117 | PF12436 | 0.302 |
DOC_USP7_UBL2_3 | 165 | 169 | PF12436 | 0.410 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.302 |
LIG_Actin_WH2_2 | 206 | 224 | PF00022 | 0.422 |
LIG_AP2alpha_1 | 208 | 212 | PF02296 | 0.449 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.518 |
LIG_BIR_III_2 | 217 | 221 | PF00653 | 0.351 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.327 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.216 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.359 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.196 |
LIG_GBD_Chelix_1 | 201 | 209 | PF00786 | 0.422 |
LIG_Integrin_RGD_1 | 182 | 184 | PF01839 | 0.422 |
LIG_LIR_Gen_1 | 130 | 139 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 130 | 134 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.598 |
LIG_PDZ_Class_2 | 263 | 268 | PF00595 | 0.680 |
LIG_Pex14_2 | 208 | 212 | PF04695 | 0.391 |
LIG_Pex14_2 | 244 | 248 | PF04695 | 0.438 |
LIG_SH2_STAP1 | 131 | 135 | PF00017 | 0.422 |
LIG_SH2_STAT3 | 142 | 145 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.318 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.422 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.566 |
LIG_SUMO_SIM_par_1 | 175 | 180 | PF11976 | 0.419 |
LIG_WRC_WIRS_1 | 14 | 19 | PF05994 | 0.441 |
LIG_WRC_WIRS_1 | 205 | 210 | PF05994 | 0.237 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.641 |
MOD_Cter_Amidation | 235 | 238 | PF01082 | 0.355 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.257 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.368 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.450 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.368 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.356 |
MOD_PKA_1 | 261 | 267 | PF00069 | 0.460 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.596 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.461 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.316 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.216 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.302 |
TRG_ENDOCYTIC_2 | 131 | 134 | PF00928 | 0.422 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.302 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.453 |
TRG_ER_diArg_1 | 104 | 107 | PF00400 | 0.422 |
TRG_ER_diArg_1 | 260 | 263 | PF00400 | 0.685 |
TRG_NLS_Bipartite_1 | 85 | 107 | PF00514 | 0.422 |
TRG_NLS_MonoExtC_3 | 102 | 107 | PF00514 | 0.402 |
TRG_NLS_MonoExtC_3 | 260 | 265 | PF00514 | 0.580 |
TRG_NLS_MonoExtN_4 | 260 | 266 | PF00514 | 0.581 |
TRG_Pf-PMV_PEXEL_1 | 144 | 149 | PF00026 | 0.422 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P809 | Leptomonas seymouri | 70% | 100% |
A0A0S4KQW6 | Bodo saltans | 44% | 94% |
A0A1X0NL61 | Trypanosomatidae | 53% | 99% |
A0A3Q8IJJ6 | Leishmania donovani | 87% | 100% |
A0A422NVW5 | Trypanosoma rangeli | 50% | 99% |
D0A3R7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AI07 | Leishmania infantum | 87% | 100% |
E9AUC8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q062 | Leishmania major | 86% | 100% |
Q9UT32 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 72% |
V5AXP2 | Trypanosoma cruzi | 52% | 88% |